Pain relief during thoracoscopic surgery
Conditions
Interventions
LB group:Prior to the start of the surgery, ultrasound-guided thoracic paravertebral nerve block was performed, and diluted bupivacaine liposomes 100mg (15ml) were administered on both T3 and T5 plane
LP group:Prior to the start of the surgery, ultrasound-guided thoracic paravertebral nerve block was performed, and 15ml of 0.3% ropivacaine was administered to both T3 and T5 planes
Sponsors
Qingdao University Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) Age range: 18-65 years old 2) BMI18-30kg/? 3) ASA I-III levels 4) Patients planning to undergo thoracoscopic surgery 5) Voluntary signing of informed consent form
Exclusion criteria
Exclusion criteria: 1) Patients with contraindications for regional blockade 2) Individuals who are allergic to or have absolute contraindications to the drugs used in the study 3) Patients with severe cardiovascular and cerebrovascular diseases, liver dysfunction, and arrhythmia 4) Patients with a history of taking chronic analgesics 5) Patients with communication barriers 6) Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total consumption of opioid drugs within 72 hours after surgery;Maximum NRS score 24 hours after surgery;Maximum NRS score 48 hours after surgery;Maximum NRS score 72 hours after surgery;Recovery time of postoperative gastrointestinal function;Postoperative pain relief frequency; | — |
Secondary
| Measure | Time frame |
|---|---|
| Maximum NRS score 6 hours after surgery;Maximum NRS score 12 hours after surgery; | — |
Countries
China
Contacts
Public ContactWei Feng
Qingdao University Affiliated Hospital
Outcome results
None listed